We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSPQ
3726
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
-2,226,371
Closed -$21.8M
AMPI
3727
DELISTED
Advanced Merger Partners Inc
AMPI
-1,245,274
Closed -$12.3M
JOFFW
3728
CALL
DELISTED
JOFF Fintech Acquisition Corp. Warrant
JOFFW
-543,470
Closed -$5.35M
JOFF
3729
DELISTED
JOFF Fintech Acquisition Corp. Class A Common Stock
JOFF
-1,975,211
Closed -$19.5M
HLAHW
3730
CALL
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Warrant
HLAHW
-66,661
Closed -$660K
KAHC
3731
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
-5,050,269
Closed -$49.7M
HLAH
3732
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
-1,229,066
Closed -$12.2M
LGV
3733
DELISTED
Longview Acquisition Corp. II
LGV
-3,532,408
Closed -$34.7M
LGV.WS
3734
CALL
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
-394,998
Closed -$3.88M
STRY.WS
3735
CALL
DELISTED
Starry Group Holdings, Inc. Warrants, each whole warrant exercisable to purchase 1.2415 shares of Class A common stock at an exercise price of $11.50 per 1.2415 shares of Class A common stock
STRY.WS
-78,481
Closed -$117K
PCPC
3736
DELISTED
Periphas Capital Partnering Corporation
PCPC
-706,390
Closed -$17.5M
PV.WS
3737
CALL
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
-252,286
Closed -$2.51M
PV.U
3738
DELISTED
Primavera Capital Acquisition Corporation Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
PV.U
-136,364
Closed -$1.36M
PV
3739
DELISTED
Primavera Capital Acquisition Corporation
PV
-1,848,023
Closed -$18.4M
LHAA
3740
DELISTED
Lerer Hippeau Acquisition Corp. Class A Common Stock
LHAA
-1,062,791
Closed -$10.4M
EPWR
3741
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
-1,226,986
Closed -$12.1M
SSAA
3742
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
-1,478,821
Closed -$14.6M
BLTSW
3743
CALL
DELISTED
Bright Lights Acquisition Corp. Warrant
BLTSW
-374,996
Closed -$3.71M
BSKYW
3744
CALL
DELISTED
Big Sky Growth Partners, Inc. Warrant
BSKYW
-150,295
Closed -$1.47M
BSKY
3745
DELISTED
Big Sky Growth Partners, Inc. Class A Common Stock
BSKY
-887,529
Closed -$8.68M
SSAAW
3746
CALL
DELISTED
Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
-233,221
Closed -$2.31M
VENAW
3747
CALL
DELISTED
Venus Acquisition Corporation Warrant
VENAW
-50,000
Closed -$517K
BLTS
3748
DELISTED
Bright Lights Acquisition Corp. Class A Common Stock
BLTS
-1,068,014
Closed -$10.6M
DHBC
3749
DELISTED
DHB Capital Corp. Class A common stock
DHBC
-1,301,223
Closed -$12.8M
DHBCW
3750
CALL
DELISTED
DHB Capital Corp. Warrant
DHBCW
-133,732
Closed -$1.31M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.